ARVINAS, INC. Total Assets
ARVINAS, INC. (ARVN) had Total Assets of $675.10 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-04
- 2026-06-30: Assets $675.10M.
- 2026-03-31: Assets $647.50M.
- 2025-12-31: Assets $717.90M.
- 2025-09-30: Assets $844.30M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $675.10M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $647.50M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $717.90M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $844.30M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $909.30M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $1.00B 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $1.09B 10-K · filed 2026-02-24 | |
| 2024-09-30 | $1.17B 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $1.28B 10-Q · filed 2024-07-30 | |
| 2024-03-31 | $1.21B 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $1.30B 10-K · filed 2025-02-11 | |
| 2023-09-30 | $1.06B 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $1.08B 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $1.18B 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $1.27B 10-K · filed 2024-02-27 | |
| 2022-09-30 | $1.33B 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $1.41B 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $1.49B 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $1.58B 10-K · filed 2023-02-23 | |
| 2021-09-30 | $1.60B 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $644.03M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $681.77M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $717.40M 10-K · filed 2022-02-28 | $717.37M 10-K · filed 2021-03-01 |
| 2020-09-30 | $271.95M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $262.58M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $282.45M 10-Q · filed 2020-04-28 | |
| 2019-12-31 | $301.64M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $209.09M 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $172.05M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $186.57M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $199.28M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $98.89M 10-Q · filed 2018-11-14 | |
| 2017-12-31 | $66.85M 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |